Can Fite Biopharma Stock Price History
| CANF Stock | USD 1.04 0.01 0.95% |
Below is the normalized historical share price chart for Can Fite Biopharma extending back to November 01, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Can Fite stands at 1.04, as last reported on the 20th of July, with the highest price reaching 1.05 and the lowest price hitting 1.03 during the day.
If you're considering investing in Can Stock, it is important to understand the factors that can impact its price. Can Fite Biopharma secures Sharpe Ratio (or Efficiency) of -0.0954, which signifies that the company had a -0.0954 % return per unit of risk over the last 3 months. Can Fite Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Can Fite's Risk Adjusted Performance of (0.10), mean deviation of 1.78, and Standard Deviation of 2.61 to double-check the risk estimate we provide. At this time, Can Fite's Liabilities And Stockholders Equity is most likely to increase significantly in the upcoming years. The Can Fite's current Common Stock is estimated to increase to about 73.2 M, while Other Stockholder Equity is projected to decrease to roughly 117.2 M. . At this time, Can Fite's Price To Book Ratio is most likely to slightly decrease in the upcoming years. The Can Fite's current Price Fair Value is estimated to increase to 2.98, while Price Earnings Ratio is projected to decrease to (1.51). Can Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of November 2012 | 200 Day MA 1.5614 | 50 Day MA 1.0634 | Beta 0.231 |
Sharpe Ratio = -0.0954
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CANF |
Estimated Market Risk
| 2.58 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Can Fite is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Can Fite by adding Can Fite to a well-diversified portfolio.
Price Book 2.4636 | Enterprise Value Ebitda 0.0965 | Price Sales 20.4687 | Shares Float 3.1 B | Wall Street Target Price 7.25 |
Can Fite Stock Price History Chart
There are several ways to analyze Can Stock price data. The simplest method is using a basic Can candlestick price chart, which shows Can Fite price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | April 23, 2025 | 1.18 |
| Lowest Price | July 3, 2025 | 1.02 |
Can Fite July 20, 2025 Stock Price Synopsis
Various analyses of Can Fite's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Can Stock. It can be used to describe the percentage change in the price of Can Fite from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Can Stock.| Can Fite Price Rate Of Daily Change | 0.99 | |
| Can Fite Price Action Indicator | (0.01) | |
| Can Fite Price Daily Balance Of Power | (0.50) |
Can Fite July 20, 2025 Stock Price Analysis
Can Stock Price History Data
The price series of Can Fite for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 0.28 with a coefficient of variation of 5.62. The prices are distributed with arithmetic mean of 1.09. The median price for the last 90 days is 1.07. The company had 1:10 stock split on 9th of January 2023. Can Fite Biopharma issued dividends on 2019-05-10.| Open | High | Low | Close | Volume | ||
07/20/2025 | 1.05 | 1.05 | 1.03 | 1.04 | ||
07/18/2025 | 1.05 | 1.05 | 1.03 | 1.04 | 37,000 | |
07/17/2025 | 1.04 | 1.05 | 1.04 | 1.05 | 105,456 | |
07/16/2025 | 1.05 | 1.05 | 1.04 | 1.05 | 33,106 | |
07/15/2025 | 1.04 | 1.05 | 1.03 | 1.05 | 64,800 | |
07/14/2025 | 1.03 | 1.04 | 1.02 | 1.03 | 99,109 | |
07/11/2025 | 1.05 | 1.05 | 1.02 | 1.03 | 31,900 | |
07/10/2025 | 1.03 | 1.04 | 1.03 | 1.03 | 36,903 | |
07/09/2025 | 1.04 | 1.04 | 1.02 | 1.03 | 39,800 | |
07/08/2025 | 1.02 | 1.03 | 1.02 | 1.03 | 54,279 | |
07/07/2025 | 1.03 | 1.04 | 1.00 | 1.02 | 97,300 | |
07/03/2025 | 1.02 | 1.04 | 1.02 | 1.02 | 67,900 | |
07/02/2025 | 1.01 | 1.04 | 1.01 | 1.03 | 56,756 | |
07/01/2025 | 1.04 | 1.05 | 0.99 | 1.04 | 182,854 | |
06/30/2025 | 1.09 | 1.09 | 1.04 | 1.05 | 223,001 | |
06/27/2025 | 1.02 | 1.04 | 1.01 | 1.04 | 106,968 | |
| 06/26/2025 | 1.07 | 1.07 | 1.03 | 1.03 | 48,800 | |
06/25/2025 | 1.06 | 1.09 | 1.05 | 1.06 | 98,928 | |
06/24/2025 | 1.04 | 1.08 | 1.04 | 1.06 | 178,079 | |
06/23/2025 | 1.05 | 1.06 | 1.03 | 1.05 | 57,125 | |
06/20/2025 | 1.06 | 1.06 | 1.03 | 1.06 | 75,900 | |
06/18/2025 | 1.06 | 1.08 | 1.05 | 1.06 | 76,491 | |
06/17/2025 | 1.14 | 1.14 | 1.02 | 1.05 | 309,675 | |
| 06/16/2025 | 1.16 | 1.17 | 1.13 | 1.14 | 1,030,500 | |
06/13/2025 | 1.08 | 1.09 | 1.05 | 1.07 | 38,950 | |
06/12/2025 | 1.11 | 1.11 | 1.07 | 1.08 | 65,800 | |
06/11/2025 | 1.11 | 1.12 | 1.09 | 1.10 | 75,914 | |
06/10/2025 | 1.08 | 1.12 | 1.08 | 1.11 | 52,000 | |
06/09/2025 | 1.12 | 1.12 | 1.08 | 1.11 | 51,300 | |
06/06/2025 | 1.10 | 1.10 | 1.08 | 1.10 | 74,100 | |
06/05/2025 | 1.08 | 1.11 | 1.07 | 1.08 | 43,763 | |
06/04/2025 | 1.10 | 1.11 | 1.09 | 1.11 | 62,688 | |
06/03/2025 | 1.12 | 1.12 | 1.09 | 1.10 | 56,500 | |
06/02/2025 | 1.07 | 1.10 | 1.07 | 1.10 | 40,900 | |
05/30/2025 | 1.08 | 1.08 | 1.06 | 1.08 | 52,377 | |
05/29/2025 | 1.07 | 1.09 | 1.06 | 1.08 | 76,700 | |
05/28/2025 | 1.06 | 1.07 | 1.05 | 1.07 | 61,541 | |
05/27/2025 | 1.03 | 1.07 | 1.03 | 1.07 | 57,621 | |
05/23/2025 | 1.03 | 1.04 | 1.02 | 1.03 | 32,596 | |
05/22/2025 | 1.03 | 1.05 | 1.03 | 1.04 | 18,500 | |
05/21/2025 | 1.05 | 1.06 | 1.03 | 1.03 | 49,565 | |
05/20/2025 | 1.06 | 1.07 | 1.03 | 1.06 | 82,300 | |
05/19/2025 | 1.05 | 1.05 | 1.02 | 1.05 | 65,448 | |
05/16/2025 | 1.03 | 1.08 | 1.03 | 1.05 | 58,200 | |
05/15/2025 | 1.04 | 1.05 | 1.03 | 1.05 | 35,638 | |
05/14/2025 | 1.08 | 1.09 | 0.99 | 1.03 | 227,492 | |
05/13/2025 | 1.07 | 1.10 | 1.06 | 1.09 | 103,200 | |
05/12/2025 | 1.10 | 1.14 | 1.08 | 1.10 | 76,313 | |
05/09/2025 | 1.13 | 1.13 | 1.08 | 1.11 | 132,436 | |
05/08/2025 | 1.12 | 1.13 | 1.09 | 1.12 | 98,400 | |
05/07/2025 | 1.11 | 1.12 | 1.09 | 1.10 | 81,021 | |
05/06/2025 | 1.14 | 1.15 | 1.08 | 1.09 | 100,300 | |
| 05/05/2025 | 1.20 | 1.20 | 1.12 | 1.15 | 213,412 | |
05/02/2025 | 1.07 | 1.13 | 1.05 | 1.13 | 57,432 | |
05/01/2025 | 1.06 | 1.06 | 1.03 | 1.04 | 112,271 | |
04/30/2025 | 1.09 | 1.09 | 1.02 | 1.09 | 221,300 | |
04/29/2025 | 1.16 | 1.18 | 1.08 | 1.09 | 137,900 | |
04/28/2025 | 1.18 | 1.19 | 1.14 | 1.15 | 74,173 | |
04/25/2025 | 1.17 | 1.17 | 1.13 | 1.13 | 239,235 | |
04/24/2025 | 1.18 | 1.20 | 1.17 | 1.17 | 95,449 | |
04/23/2025 | 1.20 | 1.20 | 1.14 | 1.18 | 183,038 |
About Can Fite Stock history
Can Fite investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Can is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Can Fite Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Can Fite stock prices may prove useful in developing a viable investing in Can Fite
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.3 M | 3.7 M | |
| Net Loss | -11.7 M | -12.3 M |
Can Fite Quarterly Net Working Capital |
|
Can Fite Stock Technical Analysis
Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Can Fite Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Can Fite's price direction in advance. Along with the technical and fundamental analysis of Can Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Can to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.71) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |